Clinical associations of serum antiendothelial cell antibodies in patients with sudden sensorineural hearing loss

Laryngoscope

Volumn 113, Issue 5, 2003, Pages 797-801

  Cadoni, Gabriella ^a,b   Agostino, Stefania ^a   Manna, Raffaele ^a   De Santis, Antonella ^a   Fetoni, Anna Rita ^a   Vulpiani, Paola ^a   Ottaviani, Fabrizio ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antiendothelial cell antibodies; Autoimmunity; Inner ear; Sudden sensorineural hearing loss

Indexed keywords

CELL ANTIBODY; ENDOTHELIAL CELL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT SELECTION; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; STRIA VASCULARIS; SUDDEN DEAFNESS;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; AUDITORY THRESHOLD; AUTOANTIBODIES; COCHLEA; ENDOTHELIUM, VASCULAR; FEMALE; HEARING LOSS, SUDDEN; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES; STRIA VASCULARIS; TREATMENT OUTCOME; VASCULITIS;

EID: 0037965960     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200305000-00006     Document Type: Article

References (20)

1. Stone JH, Francis HW. Immune-mediated inner ear disease. Curr Opin Rheumatol 2000;12:32-40.
2. Yoo TJ, Tomoda K, Stuart JM, Cremer MA, Townes AS, Kang AH. Type II collagen induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Rhinol Otol Laryngol 1983;92:267-271.
3. Joliat T, Seyer J, Bernstein J, et al. Antibodies against a 30kDa cochlear protein and type II and type IX collagens in the serum of patients with inner ear disease. Ann Otol Rhinol Laryngol 1992;101:1000-1006.
4. Boulassel MR, Deggouj N, Tomasi JP, Gersdorf M. Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases. Acta Otolaryngol 2001;121:28-34.
5. Veldman JE, Hanada T, Meeuwsen F. Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden hearing loss: a reappraisal of immune reactivity in inner ear disorders. Acta Otolaryngol (Stockh) 1993;113:303-306.
6. Toubi E, Ben-David J, Kessel A, Podoshin L, Golan TD. Autoimmune aberration in sudden sensorineural hearing loss: association with anti-cardiolipin antibodies. Lupus 1997;6:540-542.
7. Heller U, Becker EW, Zenner HP, Berg PA. Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deafness and progressive inner ear hearing loss. HNO 1998;46:583-586.
8. Mayot D, Bene MC, Dron K, Perrin C, Faure GC. Immunologic alterations in patients with sensorineural hearing disorders. Clin Immunol Immunopathol 1993;68:41-45.
9. Garcia Berrocal JR, Ramirez Camacho R. Immune response and immunopathology of the inner ear: an update. J Laryngol Otol 2000;114:101-107.
10. Nordang L, Laurent C, Mollnes TE. Complement activation in sudden deafness. Arch Otolaryngol Head Neck Surg 1998;124:633-636.
11. Belizna C, Cohen Tervaert JW. Specificity, pathogenicity, and clinical value of antiendothelial cell antibodies. Semin Arthritis Rheum 1997;27:98-109.
12. Ottaviani F, Cadoni G, Marinelli L, et al. Anti-endothelial autoantibodies in patients with sudden hearing loss. Laryngoscope 1999;109:1084-1087.
13. Tan EM, Pearson CM. Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum 1972;15:23-28.
14. Belizna C, Cohen Tervaert JW. Specificity, pathogenicity and clinical value of anti-endothelial cell antibodies. Semin Arthritis Rheum 2000;27:98-109.
15. Hill MB, Phipps JL, Milford-Ward A, Greaves M, Hughes P. Further characterization of anti-endothelial cell antibodies in systemic lupus erythematosus by controlled immunoblotting. Br J Rheumatol 1996;35:1231-1238.
16. Meroni PL, D'Cruz D, Khamashta M, Youinou O, Hughes GRV. Anti-endothelial cell antibodies: only for scientists or for clinicians too? Clin Exp Immunol 1996;104:199-202.
17. Lin DW, Trune DR. Breakdown of stria vascularis bloodlabyrinth barrier in C3H/Ipr autoimmune disease mice. Otolaryngol Head Neck Surg 1997;117:530-534.
18. Ruckenstein MJ, Keithley EM, Bennett T, Powell HC, Baird S, Harris JP. Ultrastructural pathology in the stria vascularis of the MRL-Fas lpr mouse. Hear Res 1999;131:22-28.
19. Mosnier I, Bouccara D, Sterkers O. Le surdites brusques en 1997: hypotheses etiopathogeniques, conduite a tenir, facteurs prognostiques, traitments. Ann Otolaryngol Chir Cervicofac 1997;114:251-266.
20. Leong HK, Loh KK. Prognostic factors in idiopathic sudden hearing loss. Ann Acad Med 1991;20:624-627.